FilingFirehose · free AI preview
SANGAMO THERAPEUTICS, INC
SGMO · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Delisting
Sangamo Therapeutics filed a delisting notice on April 29, 2026, signaling potential compliance or financial stress. Our 90-day monitoring window detected this single red-flag event with no cyber incidents, but this snapshot excludes the full 12-month filing history and financing context that shapes actual risk exposure. The full $49 Report adds dilution trajectory analysis, detailed 8-K context, capital raise patterns, and AI-scored governance risk signals that contextualize what the delisting notice means for equity holders.
Want the full 5-section $49 Report on SGMO?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.